Definitive Contract 75N93025C00019
Award Date
6/1/25
Potential Completion Date
5/31/28
Potential Value
$1.5M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Integral Molecular Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $600,000 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Integral Molecular Inc., a biotechnology company specializing in membrane protein research and therapeutic antibody development. The contract is for the development of "Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models", supporting...
This contract award is to Integral Molecular Inc., a biotechnology company specializing in membrane protein research and antibody development. The contract, valued at $150,000.00, was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I research project focused on biomedical research. It is designated as a total small business set-aside. Integral Molecular...
This is a definitive contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Integral Molecular Inc., a biotechnology company, for $7,510,794.00. The contract is for B-Cell Epitope Discovery and Mechanisms of Antibody Protection research and is scheduled to be completed by September 15, 2024. Integral Molecular provides a range of biomedical research services and develops products related to infectious diseases, cancer, neuroscience,...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $16,200 purchase order to Integral Molecular Inc. for membrane proteome array services (AMBIS #2194825). The firm fixed price contract will be performed in Philadelphia, Pennsylvania from November 21, 2023 through January 31, 2024. As part of NIH's efforts to advance biomedical research, this award will provide Integral Molecular services to analyze protein...
This is a $7,910,444.00 definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Integral Molecular Inc. The contract is for discovering and characterizing B cell epitopes against the viral pathogens Rift Valley Fever Virus, Crimean-Congo Hemorrhagic Fever Virus, and Enterovirus D68. The contract has a period of performance from September 16, 2024 to September 15, 2029 and was not set...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price definitive contract valued at $585,999.00 to Protein Innovation Labs, Inc., a small business concern, for the provision of reagents to support immunologic analysis of non-mammalian models. This contract was awarded under the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) Small Business Innovation...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...